Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Xiel Limited is a specialist in nuclear medicine and radiotherapy, serving the UK and Irish markets. The company primarily provides nuclear medicine and radiotherapy capital and services to hospitals, universities, research institutes and private companies, tailoring their offerings to meet specific customer needs.

MIS Healthcare is a UK-based exclusive distributor for world-leading medical manufacturers offering state-of-the-art products, including high-end medical imaging diagnostic equipment, PACS/RIS, medical consumables and diagnostic instruments. The company aims to become a leading specialist in the diagnostic imaging, radiology and oncology markets.

Oaklins S&W, one of Oaklins’ member firms in the UK, served as the corporate finance advisor to the shareholders of Xiel Limited.